Clinical Trials Browser

Gastro-enteropancreatic neuroendocrine tumor × 177Lu-octreotide, DOTA(0)-Tyr(3)- × Clear all

Gastro-enteropancreatic neuroendocrine tumor, Lymphoma, Rhabdomyosarcoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Neuroendocrine Tumors

NCT04919226 2025-09-10

COMPOSE

Phase 3 Active not recruiting

259 enrolled

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

NCT05359146 2024-04-19

Beta plus

Phase EARLY_PHASE1 Recruiting

16 enrolled

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor

NCT04915144 2023-02-21

177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs

Phase 2 Withdrawn

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Vipoma, Insulinoma, Gastrinoma, Neuroendocrine Tumors

Clinical Trials

KinLET

COMPOSE

Beta plus

177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs